AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 59517 — intervention group
Group type: COMPARATOR
Intervention: Phenindione
Number of subjects: 54
Study 30696504 — intervention group
Group type: EXPERIMENTAL
Intervention: Overfeeding by 50% (16,132 (sd 889) kJ)
Number of subjects: 12
Study 30696504 — intervention group
Group type: COMPARATOR
Intervention: Energy balance trial (10,755 (sd 593) kJ)
Number of subjects: 12
Study 27647279 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 45
Study 27647279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 26015443 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP-augmented repair
Number of subjects: 74
Study 26015443 — intervention group
Group type: COMPARATOR
Intervention: Conventional repair
Number of subjects: 74
Study 23647007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx 1: xenogenic bone substitute (pre‐hydrated collagenated cortico‐cancellous porcine bone) and free gingival graft
Number of subjects: 30
Study 23647007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx 2: free gingival graft alone
Number of subjects: 30
Study 23647007 — intervention group
Group type: COMPARATOR
Intervention: Tx 4: no further treatment (control)
Number of subjects: 30
Study 21727288 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation massage
Number of subjects: 401
Study 21727288 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural massage
Number of subjects: 401
Study 21727288 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 401
Study 19860888 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% PRO 2000/5 gel
Number of subjects: 9404
Study 19860888 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% PRO 2000/5 gel
Number of subjects: 9404
Study 19860888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9404
Study 16340516 — intervention group
Group type: EXPERIMENTAL
Intervention: Quit & Win
Number of subjects: 1849
Study 16340516 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT voucher
Number of subjects: 1849
Study 16340516 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 1849
Study 16340516 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 1849
Study 16032448 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA (Patient-controlled epidural analgesia)
Number of subjects: 58
Study 16032448 — intervention group
Group type: COMPARATOR
Intervention: CEI (Conventional continuous epidural infusion)
Number of subjects: 58
Study 16032448 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA
Number of subjects: 58
Study 16032448 — intervention group
Group type: COMPARATOR
Intervention: CEI
Number of subjects: 58
Study 12399689 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supervised brushing with 1,500-ppm fluoride toothpaste and rinsing with a beaker of water (School A)
Number of subjects: 407
Study 12399689 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supervised brushing with 1,500-ppm fluoride toothpaste and only permitted to spit out once after brushing (School B)
Number of subjects: 407
Study 12399689 — intervention group
Group type: COMPARATOR
Intervention: No daily brushing and no supply of toothpaste (School C)
Number of subjects: 407
Study 10833286 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronally Positioned Flap (CPF)
Number of subjects: 60
Study 10833286 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Technique (ET)
Number of subjects: 60
Study 10833286 — intervention group
Group type: COMPARATOR
Intervention: Surgical Debridement (Control)
Number of subjects: 60
Study 7478782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilator (IPV)
Number of subjects: 16
Study 7478782 — intervention group
Group type: COMPARATOR
Intervention: Standard aerosol and chest physiotherapy
Number of subjects: 16
Study 2179590 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention
Number of subjects: 12866
Study 2179590 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 12866
Study 347461 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental mouthwash containing cetyl pyridinium chloride
Number of subjects: 0
Study 347461 — intervention group
Group type: COMPARATOR
Intervention: Commercial mouthwash (Scope)
Number of subjects: 0
Study 347461 — intervention group
Group type: COMPARATOR
Intervention: Commercial mouthwash (Listerine)
Number of subjects: 0
Study 31867987 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in Remaking Recess only
Number of subjects: 28
Study 31867987 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in Remaking Recess with implementation support
Number of subjects: 28
Study 31146440 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-protein breakfast (HP; 350 kcal; 35 g protein)
Number of subjects: 37
Study 28103811 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive modular tiles training (2 sessions per week for 12 weeks, 1 hour per session with 13 minutes of training per participant)
Number of subjects: 60
Study 28103811 — intervention group
Group type: COMPARATOR
Intervention: Usual care provided to non-patient elderly
Number of subjects: 60
Study 25983216 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab monotherapy
Number of subjects: 396
Study 25983216 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab combined with laser
Number of subjects: 396
Study 25983216 — intervention group
Group type: COMPARATOR
Intervention: Laser monotherapy
Number of subjects: 396
Study 23495860 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol
Number of subjects: 2734
Study 23495860 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone/salmeterol
Number of subjects: 2734
Study 21195605 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 418
Study 21195605 — intervention group
Group type: COMPARATOR
Intervention: Control (routine medical care)
Number of subjects: 418
Study 19190496 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-month lamivudine monotherapy
Number of subjects: 154
Study 19190496 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 154
Study 17259157 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen (3 mg estrostilben thrice a day from the day before acrinol injection to the end of delivery)
Number of subjects: 320
Study 17259157 — intervention group
Group type: COMPARATOR
Intervention: Control (no estrogen treatment)
Number of subjects: 320
Study 15135192 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-head CPR (OTH CPR)
Number of subjects: 20
Study 15135192 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 20
Study 15135192 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 20
Study 11501645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream A (high lipid content)
Number of subjects: 19
Study 11501645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream B (moderate/low lipid content)
Number of subjects: 19
Study 11501645 — intervention group
Group type: COMPARATOR
Intervention: Control (no moisturizer)
Number of subjects: 19
Study 9932659 — intervention group
Group type: EXPERIMENTAL
Intervention: Accutrend Sensor (Boehringer Mannheim GmbH)
Number of subjects: 20
Study 8057114 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 200 mg daily
Number of subjects: 22
Study 8057114 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 22
Study 3141194 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg tamoxifen/day
Number of subjects: 40
Study 3141194 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg tamoxifen/day and 150 mg testolactone/day
Number of subjects: 40
Study 4530838 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconventional toothbrush
Number of subjects: 0
Study 4530838 — intervention group
Group type: COMPARATOR
Intervention: Standard toothbrush
Number of subjects: 0
Study 31296508 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based joyful sleep
Number of subjects: 70
Study 31296508 — intervention group
Group type: COMPARATOR
Intervention: CBT-I
Number of subjects: 70
Study 28993867 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective pelvic arterial embolisation (PAE)
Number of subjects: 38
Study 28993867 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PAE)
Number of subjects: 38
Study 25186850 — intervention group
Group type: EXPERIMENTAL
Intervention: Student Examiners (SE)
Number of subjects: 207
Study 25186850 — intervention group
Group type: COMPARATOR
Intervention: Faculty Examiners (FE)
Number of subjects: 207
Study 24009792 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mass drug administration (MDA) aiming for coverage of children between 80%-90%
Number of subjects: 32
Study 24009792 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mass drug administration (MDA) aiming for coverage > 90%
Number of subjects: 32
Study 24009792 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mass drug administration (MDA) for three years
Number of subjects: 32
Study 24009792 — intervention group
Group type: COMPARATOR
Intervention: Rule of cessation of MDA early if estimated prevalence of ocular C. trachomatis infection was less than 5%
Number of subjects: 32
Study 21315216 — intervention group
Group type: EXPERIMENTAL
Intervention: CCM plus optimal medical therapy (OMT)
Number of subjects: 428
Study 21315216 — intervention group
Group type: COMPARATOR
Intervention: OMT alone
Number of subjects: 428
Study 21315216 — intervention group
Group type: EXPERIMENTAL
Intervention: CCM plus OMT
Number of subjects: 428
Study 18990434 — intervention group
Group type: COMPARATOR
Intervention: 75 mg aspirin with 150 mg clopidogrel
Number of subjects: 50
Study 18990434 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg aspirin with 150 mg clopidogrel
Number of subjects: 50
Study 16874595 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined dietary-physical activity intervention
Number of subjects: 24
Study 15526839 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal salmon calcitonin (200 IU, thrice a week)
Number of subjects: 45
Study 15526839 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (up to 6 g/d) alone or with aluminum hydroxide (up to 3 g/d) as phosphate binders
Number of subjects: 45
Study 15526839 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal salmon calcitonin
Number of subjects: 45
Study 15526839 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 45
Study 11288783 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive glass (PG) bone replacement graft material
Number of subjects: 27
Study 11288783 — intervention group
Group type: COMPARATOR
Intervention: Expanded polytetrafluoroethylene (ePTFE) barrier membrane
Number of subjects: 27
Study 9727211 — intervention group
Group type: EXPERIMENTAL
Intervention: Harbinger (PACT model)
Number of subjects: 0
Study 9727211 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 8408456 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms iodine/day from weeks 17-18 of pregnancy until 12 months after delivery
Number of subjects: 54
Study 8408456 — intervention group
Group type: COMPARATOR
Intervention: Control group (no iodine supplementation)
Number of subjects: 54
Study 2936636 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2% miconazole nitrate and 5% benzoyl peroxide applied twice daily
Number of subjects: 0
Study 2936636 — intervention group
Group type: COMPARATOR
Intervention: Topical application of 1% isoconazole nitrate in the morning followed in the evening by 5% benzoyl peroxide
Number of subjects: 0
Study 29498033 — intervention group
Group type: EXPERIMENTAL
Intervention: Terrorism-related pictures
Number of subjects: 95
Study 29498033 — intervention group
Group type: COMPARATOR
Intervention: Neutral pictures
Number of subjects: 95
Study 25824852 — intervention group
Group type: EXPERIMENTAL
Intervention: Community treatment by experts (CTBE)
Number of subjects: 71
Study 25824852 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 71
Study 25527244 — intervention group
Group type: EXPERIMENTAL
Intervention: IF-BMOS
Number of subjects: 189
Study 25527244 — intervention group
Group type: EXPERIMENTAL
Intervention: IF-BMOS + Pro
Number of subjects: 189
Study 25527244 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 189
Study 21719490 — intervention group
Group type: EXPERIMENTAL
Intervention: Home respiratory polygraphy (RP) and home follow‐up
Number of subjects: 66
Study 21719490 — intervention group
Group type: COMPARATOR
Intervention: Hospital polysomnography and hospital follow‐up
Number of subjects: 66
Study 21719490 — intervention group
Group type: COMPARATOR
Intervention: Home RP and hospital follow‐up
Number of subjects: 66
Study 20384968 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS(®) hydromorphone
Number of subjects: 504
Study 20384968 — intervention group
Group type: COMPARATOR
Intervention: SR oxycodone
Number of subjects: 504
Study 18534364 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically treated patients with prolonged QRS duration (QRSd ≥140 ms)
Number of subjects: 0
Study 18534364 — intervention group
Group type: COMPARATOR
Intervention: ICD-treated patients with prolonged QRS duration (QRSd ≥140 ms)
Number of subjects: 0
Study 16355614 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 69
Study 16355614 — intervention group
Group type: EXPERIMENTAL
Intervention: MI plus Captopril
Number of subjects: 69
Study 16355614 — intervention group
Group type: COMPARATOR
Intervention: MI
Number of subjects: 69
Study 12622301 — intervention group
Group type: EXPERIMENTAL
Intervention: Beating the Blues (BtB)
Number of subjects: 167
Study 12622301 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 167
Study 11374327 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg oxazepam
Number of subjects: 30
Study 11374327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9604193 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL reconstruction
Number of subjects: 44
Study 9604193 — intervention group
Group type: COMPARATOR
Intervention: Control (contralateral asymptomatic knees)
Number of subjects: 44
Study 7948794 — intervention group
Group type: EXPERIMENTAL
Intervention: Rultract retractor
Number of subjects: 0
Study 7948794 — intervention group
Group type: EXPERIMENTAL
Intervention: Pittman retractor
Number of subjects: 0
Study 7948794 — intervention group
Group type: COMPARATOR
Intervention: Control (Cooley retractor, no IMA harvest)
Number of subjects: 0
Study 7948794 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall IMA retractor groups (Rultract and Pittman)
Number of subjects: 0
Study 3590300 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion (PP)
Number of subjects: 107
Study 3590300 — intervention group
Group type: COMPARATOR
Intervention: Cold storage (CS)
Number of subjects: 107
Study 30768793 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive therapy for MDD; details on dosage and duration not available.
Number of subjects: 1
Study 28332010 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised walking program
Number of subjects: 69
Study 28332010 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised walking program
Number of subjects: 69
Study 28332010 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent participants with preference
Number of subjects: 69
Study 26793643 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational pamphlet sent to intervention group after randomization.
Number of subjects: 200
Study 24293756 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestipitant (15 mg)
Number of subjects: 161
Study 21303515 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-suture
Number of subjects: 334
Study 21303515 — intervention group
Group type: COMPARATOR
Intervention: Stapling
Number of subjects: 334
Study 19467175 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate, 200 mcg once daily
Number of subjects: 168
Study 19467175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 17009541 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Chinese medicine with massage
Number of subjects: 72
Study 17009541 — intervention group
Group type: COMPARATOR
Intervention: Oral Chinese medicine only
Number of subjects: 72
Study 15297084 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFAs
Number of subjects: 300
Study 15297084 — intervention group
Group type: COMPARATOR
Intervention: corn oil
Number of subjects: 300
Study 10647548 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric resistance training for 8 weeks
Number of subjects: 10
Study 10647548 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained leg)
Number of subjects: 10
Study 9066384 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent warm blood cardioplegia
Number of subjects: 40
Study 9066384 — intervention group
Group type: COMPARATOR
Intervention: Cold blood cardioplegia
Number of subjects: 40
Study 8374913 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline (deprenyl)
Number of subjects: 20
Study 8374913 — intervention group
Group type: EXPERIMENTAL
Intervention: Lazabemide (Ro 19‐6327)
Number of subjects: 20
Study 8374913 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Selegiline and Lazabemide
Number of subjects: 20
Study 31623545 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait Enhancing and Motivating System (GEMS) during gait training
Number of subjects: 26
Study 31623545 — intervention group
Group type: COMPARATOR
Intervention: Gait training without Gait Enhancing and Motivating System
Number of subjects: 26
Study 28403910 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaungo applied twice a day for 3 weeks
Number of subjects: 34
Study 28403910 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaungo and placebo ointment applied once a day for 3 weeks
Number of subjects: 34
Study 28403910 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment applied twice a day for 3 weeks
Number of subjects: 34
Study 25514459 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 ppm ozone at 22°C
Number of subjects: 16
Study 25514459 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 ppm ozone at 32.5°C
Number of subjects: 16
Study 25514459 — intervention group
Group type: COMPARATOR
Intervention: Ozone exposure at both temperatures
Number of subjects: 16
Study 23307204 — intervention group
Group type: EXPERIMENTAL
Intervention: AdenoPlus
Number of subjects: 128
Study 23307204 — intervention group
Group type: COMPARATOR
Intervention: CC‐IFA
Number of subjects: 128
Study 22070744 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (cumulative dose 72.5 mg/kg)
Number of subjects: 400
Study 22070744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 22070744 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 400
Study 18469252 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary total antioxidant capacity (HT) diet
Number of subjects: 33
Study 18469252 — intervention group
Group type: COMPARATOR
Intervention: Low dietary total antioxidant capacity (LT) diet
Number of subjects: 33
Study 16948743 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually optimized postventricular atrial blanking period (PVAB)
Number of subjects: 207
Study 16948743 — intervention group
Group type: COMPARATOR
Intervention: Standard programming of the PVAB (nominal of 100 msec)
Number of subjects: 207
Study 12940868 — intervention group
Group type: EXPERIMENTAL
Intervention: Mix50/Mix25 (Mix50 before breakfast and Mix25 before evening meal)
Number of subjects: 116
Study 12940868 — intervention group
Group type: COMPARATOR
Intervention: Mix25 twice daily (Mix25 before both breakfast and evening meal)
Number of subjects: 116
Study 11130522 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists (n=12,699)
Number of subjects: 27743
Study 11130522 — intervention group
Group type: COMPARATOR
Intervention: Other antihypertensive drugs (n=15,044)
Number of subjects: 27743
Study 9182738 — intervention group
Group type: COMPARATOR
Intervention: HAND (hand curets)
Number of subjects: 15
Study 9182738 — intervention group
Group type: COMPARATOR
Intervention: US (standard smooth ultrasonic tip)
Number of subjects: 15
Study 9182738 — intervention group
Group type: COMPARATOR
Intervention: FINDIAM (fine grit diamond-coated ultrasonic tips)
Number of subjects: 15
Study 9182738 — intervention group
Group type: COMPARATOR
Intervention: MEDDIAM (medium grit diamond-coated ultrasonic tips)
Number of subjects: 15
Study 1359629 — intervention group
Group type: EXPERIMENTAL
Intervention: olsalazine
Number of subjects: 20
Study 1359629 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentasa
Number of subjects: 20
Study 1359629 — intervention group
Group type: EXPERIMENTAL
Intervention: All drugs
Number of subjects: 20
Study 3704609 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 0
Study 3704609 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (Duphalac)
Number of subjects: 0
Study 30507227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias modification for interpretation (CBM-I) with RNT priming
Number of subjects: 131
Study 30507227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias modification for interpretation (CBM-I) without RNT priming
Number of subjects: 131
Study 30507227 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no CBM-I)
Number of subjects: 131
Study 30507227 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM-I training (across diagnostic groups)
Number of subjects: 131
Study 27430652 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1150
Study 24123134 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 at 200 IU/day (low dose)
Number of subjects: 336
Study 24123134 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 at 2000 IU/day (high dose)
Number of subjects: 336
Study 24123134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study 22045128 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg at the orbicularis oris muscle
Number of subjects: 54
Study 22045128 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg at the corrugator supercilii muscle
Number of subjects: 54